Loomis Sayles & CO L P Amicus Therapeutics, Inc. Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $9.55 Million - $24.8 Million	-1,038,136 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $1.67 Million - $3.09 Million	124,196 Added 13.59%	1,038,136 $24 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $11.8 Million - $14.5 Million	913,940 New	913,940 $12.9 Million
Q3 2018 Nov 13, 2018	SELL	$11.6 - $16.54 $4.66 Million - $6.64 Million	-401,694 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $384,144 - $500,002	29,257 Added 7.86%	401,694 $6.27 Million

Q1 2018 May 11, 2018	BUY	$13.76 - $17.12 $5.12 Million - $6.38 Million	372,437 New	372,437 $5.6 Million

273

325M

841K

353K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.78B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.